Literature DB >> 1733969

Purification of the secretor-type beta-galactoside alpha 1----2-fucosyltransferase from human serum.

A Sarnesto1, T Köhlin, O Hindsgaul, J Thurin, M Blaszczyk-Thurin.   

Abstract

The secretor-type beta-galactoside alpha 1----2-fucosyltransferase from human serum was purified by hydrophobic chromatography on phenyl-Sepharose, ion-exchange chromatography on sulfopropyl-Sepharose, and affinity chromatography on GDP-hexanolamine-Sepharose. Final purification of the enzyme was achieved by high pressure liquid chromatography gel filtration and resulted in a homogeneous protein as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the radiolabeled protein. The native enzyme appears as a molecule of apparent Mr 150,000 as determined by gel filtration high pressure liquid chromatography. The apparent Mr of the enzyme resolved in the presence of beta-mercaptoethanol by sodium dodecyl sulfate-polyacrylamide gel electrophoresis was determined to be 50,000, indicating a multisubunit structure of the enzyme. Secretor-type alpha 1----2-fucosyltransferase is a glycoprotein as determined by WGA binding properties. A comparison of the Mr of the native blood group H gene encoded with the secretor-type beta-galactoside alpha 1----2-fucosyltransferases as well as comparison of subunit Mr for both enzymes suggests structural similarity. The alpha 1----2 linkage formed between alpha-L-fucose and terminal beta-D-galactose by the purified H- and secretor-type alpha 1----2-fucosyltransferases was determined by 1H NMR homonuclear cross-irradiation analysis of the oligosaccharide products. The substrate specificity and Km values calculated from the initial rate using various oligosaccharide acceptors showed that purified enzymes differ primarily in affinity for phenyl-beta-D-galactopyranoside and GDP-fucose as well as type 1 (Gal beta 1----3GlcNAc), 2 (Gal beta 1----4GlcNAc), and 3 (Gal beta 1----3GalNAc) oligosaccharide acceptors. The secretor-type alpha 1----2-fucosyltransferase shows significantly lower affinity than the H enzyme for phenyl-beta-D-galactopyranoside and GDP-fucose as well as for type 2 oligosaccharide acceptors. On the contrary, type 1 and 3 oligosaccharide acceptors are preferentially utilized by the secretor-type enzyme as compared with the H enzyme. The enzymes also differ in several physicochemical properties, implying nonidentity of the two enzymes (Sarnesto, A., Köhlin, T., Thurin, J., and Blaszczyk-Thurin, M. (1990) J. Biol. Chem. 265, 15067-15075).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Elevated expression of H type GDP-L-fucose:beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression.

Authors:  J Sun; J Thurin; H S Cooper; P Wang; M Mackiewicz; Z Steplewski; M Blaszczyk-Thurin
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

2.  Evidence for two distinct alpha(1,2)-fucosyltransferase genes differentially expressed throughout the rat colon.

Authors:  J P Piau; N Labarriere; G Dabouis; M G Denis
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

3.  Identification of a GDP-Fuc:Gal beta 1-3GalNAc-R (Fuc to Gal) alpha 1-2 fucosyltransferase and a GDP-Fuc:Gal beta 1-4GlcNAc (Fuc to GlcNAc) alpha 1-3 fucosyltransferase in connective tissue of the snail Lymnaea stagnalis.

Authors:  H Mulder; H Schachter; J R Thomas; K M Halkes; J P Kamerling; J F Vliegenthart
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

4.  Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity.

Authors:  B J Appelmelk; I Simoons-Smit; R Negrini; A P Moran; G O Aspinall; J G Forte; T De Vries; H Quan; T Verboom; J J Maaskant; P Ghiara; E J Kuipers; E Bloemena; T M Tadema; R R Townsend; K Tyagarajan; J M Crothers; M A Monteiro; A Savio; J De Graaff
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Molecular basis for secretor type alpha(1,2)-fucosyltransferase gene deficiency in a Japanese population: a fusion gene generated by unequal crossover responsible for the enzyme deficiency.

Authors:  Y Koda; M Soejima; Y Liu; H Kimura
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

6.  Characterization of WbiQ: An α1,2-fucosyltransferase from Escherichia coli O127:K63(B8), and synthesis of H-type 3 blood group antigen.

Authors:  Nicholas Pettit; Thomas Styslinger; Zhen Mei; Weiqing Han; Guohui Zhao; Peng George Wang
Journal:  Biochem Biophys Res Commun       Date:  2010-08-27       Impact factor: 3.575

7.  Two new FUT2 (fucosyltransferase 2 gene) missense polymorphisms, 739G-->A and 839T-->C, are partly responsible for non-secretor status in a Caucasian population from Northern Portugal.

Authors:  Jacinta Serpa; Nuno Mendes; Celso A Reis; Luis F Santos Silva; Raquel Almeida; Jacques Le Pendu; Leonor David
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

8.  Immunocytochemical approach to the structure of human blood group B and H glycoconjugate antigens in the three days old rat cochlea.

Authors:  M Remezal; P Gil-Loyzaga; R Mollicone; R Oriol
Journal:  Cell Tissue Res       Date:  1993-10       Impact factor: 5.249

9.  Identification of non-substrate-like glycosyltransferase inhibitors from library screening: pitfalls & hits.

Authors:  Masaki Ema; Yong Xu; Sebastian Gehrke; Gerd K Wagner
Journal:  Medchemcomm       Date:  2017-11-29       Impact factor: 3.597

10.  The Membrane-Bound Aspartyl Protease BACE1: Molecular and Functional Properties in Alzheimer's Disease and Beyond.

Authors:  Bastian Dislich; Stefan F Lichtenthaler
Journal:  Front Physiol       Date:  2012-02-17       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.